Literature DB >> 19285064

Involvement of neuropeptide Y Y(1) receptors in the acute, chronic and withdrawal effects of nicotine on feeding and body weight in rats.

Kartik T Nakhate1, Manoj P Dandekar, Dadasaheb M Kokare, Nishikant K Subhedar.   

Abstract

We investigated the role of neuropeptide Y Y(1) receptors in acute, chronic and withdrawal effects of nicotine with reference to feeding behavior. Rats were administered with nicotine, neuropeptide Y, neuropeptide Y Y(1) receptor agonist [Leu(31),Pro(34)]neuropeptide Y or antagonist BIBP3226 (N(2)-diphenylacetyl)-N-[(4-hydroxy-phenyl)-methyl]-D-arginine amide) via i.c.v. route, and food intake was measured at 2 and 6 h post-injection time-points. While acute nicotine or BIBP3226 reduced food intake, increase was observed following neuropeptide Y or [Leu(31),Pro(34)]neuropeptide Y. Nicotine-induced anorexia was antagonized by pre-treatment with neuropeptide Y or [Leu(31),Pro(34)]neuropeptide Y, and potentiated by BIBP3226. Furthermore, effects of chronic nicotine (i.p.) and its withdrawal, alone and in combination with BIBP3226 were evaluated with reference to feeding and body weight. Concurrent administration of BIBP3226 with nicotine prevented the development of tolerance to nicotine-induced anorexia, and withdrawal hyperphagia and weight gain. Moreover, acute BIBP3226 attenuated the hyperphagia following nicotine termination. Additionally, immunocytochemical profile of neuropeptide Y in the hypothalamus was studied following differential nicotine treatments. Acute nicotine treatment dramatically reduced neuropeptide Y immunoreactivity in the arcuate and paraventricular nuclei. Chronic nicotine administration decreased neuropeptide Y immunoreactivity in arcuate, but not in paraventricular nucleus. Nicotine withdrawal resulted in significant increase in the neuropeptide Y immunoreactivity in both the nuclei. Neuropeptide Y immunoreactivity in the lateral hypothalamus did not change following any of the treatments. The results suggest that neuropeptide Y in the arcuate and paraventricular nuclei of hypothalamus may be involved in acute, chronic and withdrawal effects of nicotine on the feeding behavior, possibly via neuropeptide Y Y(1) receptors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19285064     DOI: 10.1016/j.ejphar.2009.03.008

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: involvement of neuropeptide Y.

Authors:  B G Taksande; N R Kotagale; K T Nakhate; P D Mali; D M Kokare; K Hirani; N K Subhedar; C T Chopde; R R Ugale
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

2.  Central neuropeptide Y modulates binge-like ethanol drinking in C57BL/6J mice via Y1 and Y2 receptors.

Authors:  Angela M Sparrow; Emily G Lowery-Gionta; Kristen E Pleil; Chia Li; Gretchen M Sprow; Benjamin R Cox; Jennifer A Rinker; Ana M Jijon; José Peňa; Montserrat Navarro; Thomas L Kash; Todd E Thiele
Journal:  Neuropsychopharmacology       Date:  2012-01-04       Impact factor: 7.853

Review 3.  Metabolic effects of smoking cessation.

Authors:  Kindred K Harris; Mohan Zopey; Theodore C Friedman
Journal:  Nat Rev Endocrinol       Date:  2016-03-04       Impact factor: 43.330

4.  Neuroplastic Changes in the Superior Colliculus and Hippocampus in Self-rewarding Paradigm: Importance of Visual Cues.

Authors:  Sanjay N Awathale; Akash M Waghade; Harish M Kawade; Gouri Jadhav; Amit G Choudhary; Sneha Sagarkar; Amul J Sakharkar; Nishikant K Subhedar; Dadasaheb M Kokare
Journal:  Mol Neurobiol       Date:  2021-11-19       Impact factor: 5.590

Review 5.  Nicotinic Cholinergic System in the Hypothalamus Modulates the Activity of the Hypothalamic Neuropeptides During the Stress Response.

Authors:  Burcu Balkan; Sakire Pogun
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

6.  Anatabine, Nornicotine, and Anabasine Reduce Weight Gain and Body Fat through Decreases in Food Intake and Increases in Physical Activity.

Authors:  Patricia E Grebenstein; Paige Erickson; Martha Grace; Catherine M Kotz
Journal:  J Clin Med       Date:  2022-01-18       Impact factor: 4.241

Review 7.  Therapeutic Potential and Pharmaceutical Development of a Multitargeted Flavonoid Phloretin.

Authors:  Kartik T Nakhate; Hemant Badwaik; Rajesh Choudhary; Kalyani Sakure; Yogeeta O Agrawal; Charu Sharma; Shreesh Ojha; Sameer N Goyal
Journal:  Nutrients       Date:  2022-09-02       Impact factor: 6.706

8.  Trajectory of the main GABAergic interneuron populations from early development to old age in the rat primary auditory cortex.

Authors:  Lydia Ouellet; Etienne de Villers-Sidani
Journal:  Front Neuroanat       Date:  2014-06-02       Impact factor: 3.856

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.